Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2025-12-26 @ 12:30 AM
Study NCT ID:
NCT00604760
Status:
UNKNOWN
Last Update Posted:
2008-12-08
First Post:
2008-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia
Sponsor:
Memory Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MEM 3454-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Amy S. Domanowski, Ph.D., Head Regulatory Affairs
Old Organization:
Memory Pharmaceuticals Corp.